ARMP vs ILMN · $70.2M cap vs rev $2.25B
Armata Pharmaceuticals Inc (ARMP) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Armata Pharmaceuticals Inc (ARMP) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
ARMP does not have a complete income-statement cache yet.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
ARMP currently screens at market cap $70.2M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the ARMP and ILMN stock pages for the full models.
Not investment advice.